'Misunderstood by the market': Why this fundie says this ASX 200 mining share is undervalued right now

This fundie believes there are good times to come for the Iluka share price.

Key points
  • The Iluka share price could be in for a good run, with First Sentier's Tim Canham reportedly bullish on the stock 
  • The fundie is said to like the outlook for mineral sands and the company's business in Western Australia 
  • That's despite many materials shares having struggled through 2022 so far 

S&P/ASX 200 Index (ASX: XJO) mining shares have struggled recently, and Iluka Resources Limited (ASX: ILU) hasn't dodged its sector's carnage.

The mineral sands producer's stock is currently trading at $9.59. That's 25% lower than the record high it reached in April. Meanwhile, the S&P/ASX 200 Materials Index (ASX: XMJ) is down 10% year to date.

But First Sentier senior portfolio manager Tim Canham appears bullish on the Iluka share price. The fundie reportedly believes the materials share is undervalued and ready to benefit from a lack of supply.

Let's take a closer look at what the expert has tipped will drive the ASX 200 mining share higher.

Female miner in hard hat and safety vest on laptop with mining drill in background.

Image source: Getty Images

ASX 200 mining share tipped to take off

Iluka is an ASX 200 mineral sands miner developing and operating projects across Australia. From its mineral sands, Iluka produces minerals such as zircon, titanium, and rare-earth elements.

Canham believes there's plenty to be hopeful about when it comes to mineral sands. The fundie told the Australian Financial Review:

[T]here are headwinds from global recession fears and Chinese housing issues, but the fundamental lack of supply in mineral sands products is very real.

Canham also thinks Iluka's push to construct a rare earth refinery in Western Australia is "misunderstood by the market and undervalued", continuing:

As a manufacturing destination, [Western Australia] looks attractive with some of the lowest gas prices in the world.

Iluka has doubled down on its Australian business recently. It spun out its West African mineral sands leg into Sierra Rutile Holdings Limited (ASX: SRX) earlier this week.

And Canham isn't the only expert expecting big things from the ASX 200 mining share.

Goldman Sachs has slapped Iluka shares with a $13.80 price target and a buy rating, my Fool colleague James reports. That implies a potential 44% upside.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Couple using their digital tablet together.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

Trading near 12-month lows, this ASX retailer could be set for a 54% gain

This baby goods retailer still has ample room to grow.

Read more »